Niva Bupa Health Insurance Company Limited

₹ 7,407 crore

hat the category is gaining relevance amongst all demographics. We achieved GWP (without 1/n) of ₹ 7,407 crore with a 32% growth & GWP (with 1/n) of ₹ 6,762 crore with a 21% growth over FY24. Our I-GAAP PAT wa

32%

aining relevance amongst all demographics. We achieved GWP (without 1/n) of ₹ 7,407 crore with a 32% growth & GWP (with 1/n) of ₹ 6,762 crore with a 21% growth over FY24. Our I-GAAP PAT was ₹ 214 cro

₹ 6,762 crore

emographics. We achieved GWP (without 1/n) of ₹ 7,407 crore with a 32% growth & GWP (with 1/n) of ₹ 6,762 crore with a 21% growth over FY24. Our I-GAAP PAT was ₹ 214 crore which grew by 161% & IFRS PAT was ₹ 20

21%

ieved GWP (without 1/n) of ₹ 7,407 crore with a 32% growth & GWP (with 1/n) of ₹ 6,762 crore with a 21% growth over FY24. Our I-GAAP PAT was ₹ 214 crore which grew by 161% & IFRS PAT was ₹ 203 crore, gr

₹ 214 crore

ith a 32% growth & GWP (with 1/n) of ₹ 6,762 crore with a 21% growth over FY24. Our I-GAAP PAT was ₹ 214 crore which grew by 161% & IFRS PAT was ₹ 203 crore, growing by 91% over last year. Combined ratio for th

161%

th 1/n) of ₹ 6,762 crore with a 21% growth over FY24. Our I-GAAP PAT was ₹ 214 crore which grew by 161% & IFRS PAT was ₹ 203 crore, growing by 91% over last year. Combined ratio for the year was 96% (wi

₹ 203 crore

rore with a 21% growth over FY24. Our I-GAAP PAT was ₹ 214 crore which grew by 161% & IFRS PAT was ₹ 203 crore, growing by 91% over last year. Combined ratio for the year was 96% (without 1/n) & 101% (with 1/n

91%

ver FY24. Our I-GAAP PAT was ₹ 214 crore which grew by 161% & IFRS PAT was ₹ 203 crore, growing by 91% over last year. Combined ratio for the year was 96% (without 1/n) & 101% (with 1/n). Our market sh

96%

by 161% & IFRS PAT was ₹ 203 crore, growing by 91% over last year. Combined ratio for the year was 96% (without 1/n) & 101% (with 1/n). Our market share increased to 9.4% from 9.1% in FY24 in the retail

101%

as ₹ 203 crore, growing by 91% over last year. Combined ratio for the year was 96% (without 1/n) & 101% (with 1/n). Our market share increased to 9.4% from 9.1% in FY24 in the retail health segment and

9.4%

Combined ratio for the year was 96% (without 1/n) & 101% (with 1/n). Our market share increased to 9.4% from 9.1% in FY24 in the retail health segment and we continue to be one of the fastest growing co

9.1%

atio for the year was 96% (without 1/n) & 101% (with 1/n). Our market share increased to 9.4% from 9.1% in FY24 in the retail health segment and we continue to be one of the fastest growing companies in

“3 MD & CEO Commentary on FY25 Performance We are pleased to close FY25 on a strong note and are optimistic about maintaining a positive trajectory into the future.”

“FY25 was a very important year for our organisation as Niva Bupa was listed on the Stock Exchanges on November 14, 2024 - a significant milestone for our company.”

“Our Weighted Episodal NPS for FY25 was 55, improving by 5 points over FY24, reflecting our continued commitment to excellent customer service.”

Notes

2

Note

1

PROVIDER CREATES CLAIMS

1

PAYABILITY CHECK

1

TARIFF APPLICATION

1

Notes

3 MD & CEO Commentary on FY25 Performance We are pleased to close FY25 on a strong note and are optimistic about maintaining a positive trajectory into the future. We are very excited by the significant opportunity that health insurance presents and we believe that the category is gaining relevance amongst all demographics. We achieved GWP (without 1/n) of ₹ 7,407 crore with a 32% growth & GWP (with 1/n) of ₹ 6,762 crore with a 21% growth over FY24. Our I-GAAP PAT was ₹ 214 crore which grew by 161% & IFRS PAT was ₹ 203 crore, growing by 91% over last year. Combined ratio for the year was 96% (without 1/n) & 101% (with 1/n). Our market share increased to 9.4% from 9.1% in FY24 in the retail health segment and we continue to be one of the fastest growing companies in health insurance. FY25 was a very important year for our organisation as Niva Bupa was listed on the Stock Exchanges on November 14, 2024 - a significant milestone for our company. We continued to being recognised as India’s

Note

1. NPS score of few critical touch points (claims discharge, service, policy issuance, renewal etc.) is combined into a single, weighted NPS score, calculated as weighted average by response method, for the organisation 14 3 Multi-Channel & Diversified Distribution with Emphasis on Digital Sales Diversified Channel Mix with Strong Focus on Growing High Value Channels Pan-India Presence FY2025 (%) Banks and Other Corporate Agents Individual Agents Corporate Agent - Banks Corporate Agent - Others Brokers (1) Direct Business Others (2) 30.6% 0.6% 11.5% 29.7% 20.1% 7.5%

Notes

1. Brokers include PB Fintech (Policybazaar) 2. Others include Web Aggregators,, Insurance Marketing Firms, Point of Sales and Common Service Centers 212 Branches 180,905 Individual Agents (+8K in Q4’FY25) 103 Banca & Other Corporate Agency Partners (+6 in Q4’FY25) 540 Brokers (+24 in Q4’FY25) Metrics as of FY2025 +94 more Corporate Agents Insurance Brokers +535 Others 15 4 Our Technology Enables us to Serve Customers Anywhere, Anytime Digital Self-Serve Capabilities Insta Assist and Cia Chatbot Claim Submission One-Click Renewal Support Submit Claim Submit Claim Renew policy ABC 99.9% new policies applied via website and mobile apps 88.3% renewals completed without human intervention 86.0% cashless claims processed in <30 mins 91.5% claims submitted digitally Note: Metrics for FY2025 16 4 Our Value Chain is Significantly Automated with Analytics Embedded into Operations Partner Onboarding Customer Sourcing Underwriting Claims Management Policy Renewal Modular API based partner integra

TARIFF APPLICATION

APPROVED AMOUNT ALL RULES CHECKED BY SYSTEM From ~30 mins to less than couple of minutes Reduction in processing time for pre-authorization of cashless claims through manual processing vs auto-adjudication claims system Enables faster processing of retail cashless claims, reduces errors and promotes cost-savings 147 140 128 130 123 100 101 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025 Retail Health Claim Cost Index reflects Niva Bupa YOY average claim size with FY2019 as base year. The change in index is on account of medical cost 4 inflation, change in disease mix, medical advancement etc. Note: 1. All indemnity claims excl. covid claims, 2. CAGR Period - FY2019 to FY2025 21 6 Focus on Talent Management & Execution 2021 2022 2023 2024 2025 Top 25 India’s Best WorkplacesTM in BFSI 2025 22 Agenda Our Strategy Financial Performance Financial Performance Gross Written Premium (GWP) Combined Ratio CAGR: 28.9% 5,607.6 4,073.0 (₹ in Crores) 6,762.2 Combined Ratio 97.2% 98.8% 101.2% 96.1%